DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB16177
| null |
ABH001
|
502-97-6
|
YRZ676PGU6
|
Glycolide
|
RKDVKSZUMVYZHH-UHFFFAOYSA-N
|
DB16178
| null |
Froniglutide
|
1417579-81-7
|
3V0J65M6J3
|
Glucagon like peptide-1 Elastin like peptide-120 fusion protein | Glymera | L-Histidylglycyl-L-α-glutamylglycyl-L-threonyl-L-phenylalanyl-L-threonyl-L-seryl-L-α-aspartyl-L-valyl-L-seryl-L-seryl-L-tyrosyl-L-leucyl-L-α-glutamylglycyl-L-glutaminyl-L-alanyl-L-alanyl-L-lysyl-L-α-glutamyl-L-phenylalanyl-L-isoleucyl-L-alanyl-L-tryp
| null |
DB16179
| null |
Gontivimab
|
1257358-38-5
|
DY8W536BUY
|
Anti-rsv protein f nanobody alx-0171 | Gontivimab
| null |
DB16180
| null |
GP2 peptide
|
160790-21-6
|
FQA52PV28G
|
Gp-2 her2-derived, hla-a2+ restricted peptide | GP2 peptide
| null |
DB16181
| null |
ISIS 2503
|
149957-14-2
|
I444I66XWH
|
H-ras antisense oligodeoxynucleotide isis 2503
| null |
DB16182
| null |
CXD101
|
934828-12-3
|
5TNV87ICD2
|
Hdac inhibitor cxd101 | Hdac-in-4
|
JHDZMASHNBKTPS-UHFFFAOYSA-N
|
DB16183
| null |
Hemoporfin
|
14459-29-1
|
HBT6M5H379
|
Haematoporphyrin | Hematoporphyrin | Hematoporphyrin ix | Hemoporfin | Photodyn
|
UJKPHYRXOLRVJJ-AMPAVEGJSA-N
|
DB16184
| null |
Hetrombopag
|
1257792-41-8
|
9WGT51BDDL
| null |
BDGGFTDRPHKXFC-QYQHSDTDSA-N
|
DB16185
| null |
HQP1351
|
1257628-77-5
|
KV1M7Q3CBP
|
Hqp-1351 free base | Hqp1351 free base | Olverembatinib
|
TZKBVRDEOITLRB-UHFFFAOYSA-N
|
DB16186
| null |
PEN-866
|
1472614-83-7
|
56DL1J49LR
|
Hsp90-targeted sn-38 conjugate pen-866
|
QTPZAEAYDWMVJO-GGCSAXROSA-N
|
DB16187
| null |
C-peptide
|
59112-80-0
|
O2J76Y002M
|
C-peptide | Human c-peptide | Human proinsulin c-peptide | Insulin c-peptide | Proinsulin c-peptide | Proinsulin c-peptide (human)
|
VOUAQYXWVJDEQY-QENPJCQMSA-N
|
DB16188
| null |
Befovacimab
|
2156634-62-5
|
8FFQ0L4R3B
|
Befovacimab | Human tissue factor pathway inhibitor-neutralizing antibody (bay 1093884) | Immunoglobulin g2, anti-(human tissue factor pathway inhibitor) (human monoclonal 1093884 .gamma.2-chain), disulfide with human monoclonal 1093884 .lambda.-chain, dimer
| null |
DB16189
| null |
Ibezapolstat
|
1275582-97-2
|
5K543KNC5P
|
Ibezapolstat
|
DEGSGBKTODESHH-UHFFFAOYSA-N
|
DB16190
| null |
Idursulfase beta
|
1271734-34-9
|
5GCF8EPY6R
|
Hunterase | Iduronate 2-sulfatase (a-l-iduronate sulfate sulfatase), human proenzyme produced in cho cells (glycoform beta) | Idursulfase .beta. | Idursulfase beta
| null |
DB16191
| null |
Ifidancitinib
|
1236667-40-5
|
R105E71J13
|
Ifidancitinib
|
OYFMQDVLFYKOPZ-UHFFFAOYSA-N
|
DB16192
| null |
Imaradenant
|
1321514-06-0
|
770140J08A
|
Imaradenant
|
NCWQLHHDGDXIJN-UHFFFAOYSA-N
|
DB16193
| null |
Tovinontrine
|
2062661-53-2
|
W248Y1AKOR
|
6-((3S,4S)-4-METHYL-1-(2-PYRIMIDINYLMETHYL)-3-PYRROLIDINYL)-3-(TETRAHYDRO-2H-PYRAN-4-YL)IMIDAZO(1,5-A)PYRAZIN-8(7H)-ONE | 6-[(3S,4S-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3-tetrahydropyran-4-yl-7H-imadazo[1,5-a]pyrazin-8-one | 6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-3- tetrahydropyran-4-yl-7H-imidazo[1,5-a]pyrazin-8-one | IMIDAZO(1,5-A)PYRAZIN-8(7H)-ONE, 6-((3S,4S)-4-METHYL-1-(2-PYRIMIDINYLMETHYL)-3-PYRROLIDINYL)-3-(TETRAHYDRO-2H-PYRAN-4-YL)-
|
GWGNPYYVGANHRJ-GDBMZVCRSA-N
|
DB16194
| null |
Imidazole-4-carboxylic acid
|
1072-84-0
|
AE82Z8U4GJ
|
4-Carboxyimidazole | 4-Imidazolecarboxylic acid
|
NKWCGTOZTHZDHB-UHFFFAOYSA-N
|
DB16195
| null |
Indatuximab ravtansine
|
1238517-16-2
|
XGL4M23834
|
Indatuximab ravtansine | N2'-Deacetyl-N2'-[4-Methyl-4-(Oxobuthyldithio)-1-Oxopentyl]-Maytansine-Chimerized Anti-Cd138 Igg4 Monoclonal Antibody
| null |
DB16196
| null |
INVAC-1
|
1708137-44-3
|
S8GQZ8LF0D
|
Human telomerase reverse transcriptase (htert) dna vaccine invac-1 | Invac-1, a double stranded dna plasmid vaccine construct encoding ubiquitin-human telomerase reverse transcriptase (htert) fusion protein
| null |
DB16197
| null |
Iodine I-131 monoclonal antibody 81C6
|
1000874-23-6
|
D4E1UP3RMV
|
81c6, a murine igg2 anti-tenascin monoclonal antibody labeled with iodine 131 (I-131) | Anti-tenascin 81C6 monoclonal antibody labeled w/ I 131 | Anti-tenascin monoclonal antibody 81c6-I-131 | Iodine i 131 moab 81c6 | Iodine i 131 monoclonal antibody 81c6 | Iodine I-131 monoclonal antibody 81c6 | Moab, 81c6, murine, iodine-I-131 radiolabeled, to human glioma | Neuradiab
| null |
DB16198
| null |
IONIS-FGFR4Rx
|
1416376-17-4
|
YJ4APB5MQC
|
Ionis-fgfr4rx | Isis-fgfr4rx
| null |
DB16199
| null |
Eplontersen
|
1637600-16-8
|
0GRZ0F5XJ6
|
Akcea ttr lrx | AKCEA-TTR-LRx | Eplontersen | Ion-ttr-lrx | Ionis-ttr-lrx
| null |
DB16200
| null |
Iptacopan
|
1644670-37-0
|
8E05T07Z6W
|
4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl) benzoic acid | BENZOIC ACID, 4-((2S,4S)-4-ETHOXY-1-((5-METHOXY-7-METHYL-1H-INDOL-4-YL)METHYL)-2-PIPERIDINYL)- | Iptacopan
|
RENRQMCACQEWFC-UGKGYDQZSA-N
|
DB16201
| null |
ISIS 104838
|
250755-32-9
|
8BLG99WDHS
|
ISIS-104838
| null |
DB16202
| null |
IONIS-HBVRx
|
1403787-62-1
|
Z87O6SM01N
|
IONIS HBVRx | Isis-gsk3rx
| null |
DB16203
| null |
Isopentane
|
78-78-4
|
ZH67814I0O
|
Methylbutane
|
QWTDNUCVQCZILF-UHFFFAOYSA-N
|
DB16204
| null |
Isoquinoline, 7-(2-(3,6-dihydro-4-(3-(trifluoromethyl)phenyl)-1(2h)-pyridinyl)ethyl)-
|
335267-09-9
|
5WX0OAF07I
| null |
ZXXHOPNSTZKWRI-UHFFFAOYSA-N
|
DB16205
| null |
Ispronicline
|
252870-53-4
|
3E05NBH9V5
|
Ispronicline
|
RPCVIAXDAUMJJP-PZBABLGHSA-N
|
DB16206
| null |
Itepekimab
|
2226742-52-3
|
WV9KZ9PS1A
|
Immunoglobulin igg4 (230-proline), anti-(human interleukin 33) (human monoclonal regn3500 .gamma.4-chain), disulfide with human monoclonal regn3500 .kappa.-chain, dimer | Itepekimab
| null |
DB16207
| null |
Itolizumab
|
1116433-11-4
|
XQQ2RHV14N
|
Itolizumab
| null |
DB16208
| null |
Ivuxolimab
|
2128729-41-7
|
APS3IS9D6W
|
Anti-OX40 Antibody PF-04518600 | Ivuxolimab
| null |
DB16209
| null |
Janagliflozin
|
1800115-22-3
|
WK4RT85HCA
| null |
WDBIPGHUEJEKTC-CGTLGCROSA-N
|
DB16210
| null |
Kisspeptin-10
|
374675-21-5
|
FS1N52VS3S
|
Human metastin 45-54 | Kisspeptin-10 (human)
| null |
DB16211
| null |
KAI-1678
|
1041004-14-1
|
32P8I5VL5A
| null | null |
DB16212
| null |
Ladarixin
|
849776-05-2
|
DEH7Q6472O
|
Ladarixin
|
DDLPYOCJHQSVSZ-SSDOTTSWSA-N
|
DB16213
| null |
Ladostigil
|
209394-27-4
|
SW3H1USR4Q
|
Ladostigil | Tv-3326 free base
|
LHXOCOHMBFOVJS-OAHLLOKOSA-N
|
DB16214
| null |
Landipirdine
|
1000308-25-7
|
J0NX985GDI
|
Landipirdine
|
MTTHRRVVGMPYQG-ZDUSSCGKSA-N
|
DB16215
| null |
Lapaquistat
|
189059-71-0
|
PEZ79BV72X
|
Lapaquistat
|
HDGUKVZPMPJBFK-LEAFIULHSA-N
|
DB16216
| null |
Lazertinib
|
1903008-80-9
|
4A2Y23XK11
|
2-PROPENAMIDE, N-(5-((4-(4-((DIMETHYLAMINO)METHYL)-3-PHENYL-1H-PYRAZOL-1-YL)-2-PYRIMIDINYL)AMINO)-4-METHOXY-2-(4-MORPHOLINYL)PHENYL)- | Lazertinib | N-(5-((4-(4-((DIMETHYLAMINO)METHYL)-3-PHENYL-1H-PYRAZOL-1-YL)PYRIMIDIN-2-YL)AMINO)-4-METHOXY-2-MORPHOLINOPHENYL)ACRYLAMIDE
|
RRMJMHOQSALEJJ-UHFFFAOYSA-N
|
DB16217
| null |
Leniolisib
|
1354690-24-6
|
L22772Z9CP
|
Cdz-173 free base | Cdz173 free base | Leniolisib
|
MWKYMZXCGYXLPL-ZDUSSCGKSA-N
|
DB16218
| null |
Lerociclib
|
1628256-23-4
|
WBH8AY6ENB
|
G1t38 free base | Lerociclib
|
YPJRHEKCFKOVRT-UHFFFAOYSA-N
|
DB16219
| null |
Levonadifloxacin
|
154357-42-3
|
8WHH66L098
|
(s)-(-)-nadifloxacin | Levonadifloxacin | Nadifloxacin, (s)- | Wck 771 free base | Wck-771 free base | Wck771 free base
|
JYJTVFIEFKZWCJ-JTQLQIEISA-N
|
DB16220
| null |
Lonapegsomatropin
|
1934255-39-6
|
OP35X9610Y
|
Lonapegsomatropin | lonapegsomatropin-tcgd | RhGH-PEG | Transconpeg hGH | Transconpeg-hGH
| null |
DB16221
| null |
Lonaprisan
|
211254-73-8
|
F5Z5EL4D26
|
Lonaprisan
|
VHZPUDNSVGRVMB-RXDLHWJPSA-N
|
DB16222
| null |
Loncastuximab tesirine
|
1879918-31-6
|
7K5O7P6QIU
|
Humanized monoclonal immunoglobulin G1 antibody directed against human CD19 conjugated to SG3199 through A protease cleavable valine-alanine linker | Loncastuximab tesirine | loncastuximab tesirine-lpyl
| null |
DB16223
| null |
Lunasine
|
6901-22-0
|
80R70AS7M1
|
(-)-lunasine | Lunasin | Lunasine, (-)-
|
GUIBZZYABLMRRD-CQSZACIVSA-N
|
DB16224
| null |
Lutikizumab
|
1791411-57-8
|
15FAZ725S0
|
Immunoglobulin, anti-(interleukin 1.beta./interleukin 1.alpha.) (synthetic human a-1234138 heavy chain), disulfide with synthetic human a-1234138 light chain, dimer | Lutikizumab
| null |
DB16225
| null |
Magrolimab
|
2169232-81-7
|
90YIEHRFJ9
|
5F9 | Anti-cd47 monoclonal antibody hu5f9-g4 | Immunoglobulin g4-kappa, anti-(homo sapiens cd47 (integrin associated protein, iap, mer6, oa3)), monoclonal antibodygamma4 heavy chain (1-444) (vh (homo sapiens ighv1-3*01 (87.8%)-(ighd)-ighj4*01 (100%)) (8.8.10) (1-117)-homo sapiens ighg4*01 (ch1 (118-2 | Immunoglobulin g4(225-proline), anti-(human cd47 antigen) (human-mus musculus monoclonal hu5f9-g4 .gamma.4-chain), disulfide with human-mus musculus monoclonal hu5f9-g4 .kappa.-chain, dimer | Magrolimab
| null |
DB16226
| null |
Maralixibat
|
716313-53-0
|
UYB6UOF69L
|
Lopixibat | Lopixibat cation | Maralixibat | Maralixibat cation
|
STPKWKPURVSAJF-LJEWAXOPSA-N
|
DB16227
| null |
Masilukast
|
136564-68-6
|
2QJ3R1H23S
|
Masilukast
|
ULMFXAMQUGLVGA-LJQANCHMSA-N
|
DB16228
| null |
Mavelertinib
|
1776112-90-3
|
YXX2180047
|
Egfr t790m inhibitor pf-06747775 | Mavelertinib
|
JYIUNVOCEFIUIU-GHMZBOCLSA-N
|
DB16229
| null |
Mesdopetam
|
1403894-72-3
|
HD4QV8GX26
|
Mesdopetam
|
OSBPYFBXSLJHCR-UHFFFAOYSA-N
|
DB16230
| null |
NSI-189
|
1270138-40-3
|
YVE9U408ZL
| null |
DYTOQURYRYYNOR-UHFFFAOYSA-N
|
DB16231
| null |
Methfuroxam
|
28730-17-8
|
4K9VG91RQZ
|
Furavax | Trivax
|
ZWJNEYVWPYIKMB-UHFFFAOYSA-N
|
DB16232
| null |
Milciclib Maleate
|
802539-81-7
|
688000M8S8
|
Milciclib
|
RXZMYLDMFYNEIM-UHFFFAOYSA-N
|
DB16233
| null |
Milvexian
|
1802425-99-5
|
0W79NDQ608
|
Milvexian
|
FSWFYCYPTDLKON-CMJOXMDJSA-N
|
DB16234
| null |
Miricorilant
|
1400902-13-7
|
311Y5GV21M
|
Miricorilant
|
GVVUZBSCYAVFTI-IYARVYRRSA-N
|
DB16235
| null |
Mirvetuximab
|
1453084-36-0
|
4MFH3B1EFU
|
Immunoglobulin g1, anti-(human folate receptor .alpha.) (human-mus musculus monoclonal m9346a heavy chain), disulfide with human-mus musculus monoclonal m9346a light chain, dimer | Mirvetuximab
| null |
DB16236
| null |
Mitapivat
|
1260075-17-9
|
2WTV10SIKH
|
Mitapivat | Pkr-in-1
|
XAYGBKHKBBXDAK-UHFFFAOYSA-N
|
DB16237
| null |
Modipafant
|
122957-06-6
|
1DMI0E5023
|
Modipafant
|
ODRYSCQFUGFOSU-SSEXGKCCSA-N
|
DB16238
| null |
Modithromycin
|
736992-12-4
|
9MAY4E090U
|
Modithromycin
|
WLGSYOKBEDVHQB-XSKCQLPHSA-N
|
DB16239
| null |
Molibresib
|
1260907-17-2
|
5QIO6SRZ2R
|
Bet inhibitor gsk525762 | Molibresib
|
AAAQFGUYHFJNHI-SFHVURJKSA-N
|
DB16240
| null |
BMS-813160
|
1286279-29-5
|
83U7957287
| null |
CMVHFGNTABZQJU-HCXYKTFWSA-N
|
DB16241
| null |
Apinocaltamide
|
1838651-58-3
|
3Z7U1U8Z9E
|
Benzeneacetamide, N-[1-[(5-cyano-2-pyridinyl)methyl]-1H-pyrazol-3-yl]-4-[1-(trifluoromethyl)cyclopropyl]- | N-(1-((5-CYANOPYRIDIN-2-YL)METHYL)-1H-PYRAZOL-3-YL)-2-(4-(1-(TRIFLUOROMETHYL)CYCLOPROPYL)-PHENYL)ACETAMIDE | N-[1-(5-Cyano-pyridin-2-ylmethyl)-1H-pyrazol-3-yl]-2-[4-(1-trifluoromethyl-cyclopropyl-phenyl]-acetamide | N-[1-[(5-Cyano-2-pyridinyl)methyl]-1H-pyrazol-3-yl]-4-[1-(trifluoromethyl)cyclopropyl]benzeneacetamide | N-{1-[(5-cyanopyridin-2-yl)methyl]-1H-pyrazol-3-yl}-2- {4-[1-(trifluoromethyl)cyclopropyl]phenyl}acetamide
|
LSYANGLAZUZYFX-UHFFFAOYSA-N
|
DB16242
| null |
Dovramilast
|
340019-69-4
|
1Z08G7438A
|
Cyclopropanecarboxamide, N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-3-oxo-1H-isoindol-4-yl]- | N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2- (methanesulfonyl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol- 4-yl}cyclopropanecarboxamide | N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methanesulfonyl)ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}cyclopropanecarboxamide
|
QDZOBXFRIVOQBR-LJQANCHMSA-N
|
DB16243
| null |
TBA-7371
|
1494675-86-3
|
R3T98GBE3C
| null |
VDRYGTNDKXIPSK-UHFFFAOYSA-N
|
DB16244
| null |
MK-0773
|
606101-58-0
|
5730VNW22X
| null |
GBEUKTWTUSPHEE-JWJWXJQQSA-N
|
DB16245
| null |
Human Lactoferrin Peptide hLF1-11
|
183623-03-2
|
72YOI2Q5AK
|
Human lactoferrin 1-11 | N-terminal peptide of human lactoferrin 1-11
| null |
DB16246
| null |
Nafithromycin
|
1691240-78-4
|
75F74Y2R70
|
Nafithromycin
|
RLFCSBSRGRJFRO-BRUOOUDCSA-N
|
DB16247
| null |
Nangibotide
|
2014384-91-7
|
59HD7BLX9H
|
Nangibotide
| null |
DB16248
| null |
Nanoparticle Epirubicin
| null | null |
Micellar nanoparticle-encapsulated epirubicin | Nanoparticle epirubicin
| null |
DB16249
| null |
Naphthoquine
|
173531-57-2
|
TRY8UD4E2H
| null |
VEVMYTDOWUQLGI-UHFFFAOYSA-N
|
DB16250
| null |
Nazartinib
|
1508250-71-2
|
KE7K32EME8
|
Nazartinib
|
IOMMMLWIABWRKL-WUTDNEBXSA-N
|
DB16251
| null |
Necuparanib
|
1415139-34-2
|
ULS0NT2D68
|
M-402 free acid | M402 free acid | Necuparanib
| null |
DB16252
| null |
Nedisertib
|
1637542-33-6
|
GN429E725A
| null |
MOWXJLUYGFNTAL-DEOSSOPVSA-N
|
DB16253
| null |
Nemiralisib
|
1254036-71-9
|
OEP8JJ3OZR
|
Nemiralisib
|
MCIDWGZGWVSZMK-UHFFFAOYSA-N
|
DB16254
| null |
Nevanimibe
|
133825-80-6
|
VK9OS8R205
|
Atr-101 free base | Nevanimibe
|
PKKNCEXEVUFFFI-UHFFFAOYSA-N
|
DB16255
| null |
Nidufexor
|
1773489-72-7
|
CJ1PL0TE6J
|
Nidufexor
|
JYTIXGYXBIBOMN-UHFFFAOYSA-N
|
DB16256
| null |
Ningetinib
|
1394820-69-9
|
PW3Q92Z6A4
|
Ct-053 free base | Ct-053-ptsa free base | Ct053ptsa free base
|
VQYYQSZNRVQLIS-UHFFFAOYSA-N
|
DB16257
| null |
Nipocalimab
|
2211985-36-1
|
87M90CV8NC
|
Immunoglobulin g1, anti-(human neonatal fc receptor) (human monoclonal m281 .gamma.-1 chain), disulfide with human monoclonal m281 .lambda.-chain, dimer | Nipocalimab
| null |
DB16258
| null |
Nirsevimab
|
1989556-22-0
|
VRN8S9CW5V
|
Immunoglobulin g1-kappa, anti-(human respiratory syncytial virus fusion glycoprotein f0 (protein f))human monoclonal antibody.gamma.1 heavy chain (1-456) (human vh (homo sapiens ighv1-69*01(ighd)-ighj4*01 (90.1%)) (8.8.19) (1-126) -homo sapiens ighg1*03 | Immunoglobulin g1, anti-(human respiratory syncytial virus fusion protein)(human monoclonal med18897 .gamma.1-chain), disulfide with monoclonal med18897 .kappa.-chain, dimer | Nirsevimab
| null |
DB16259
| null |
Nolasiban
|
1477482-19-1
|
3765U8A1EC
|
Erlosiban | Nolasiban
|
OLUJSZLBWZWGJT-HGBKYHTQSA-N
|
DB16260
| null |
norUrsodeoxycholic acid
|
99697-24-2
|
8A5G600D9V
|
24-norursodeoxycholic acid | Nor-ursodeoxycholic acid | Norucholic acid | NorUrsodeoxycholic Acid
|
QYYDXDSPYPOWRO-JHMCBHKWSA-N
|
DB16261
| null |
Odevixibat
|
501692-44-0
|
2W150K0UUC
|
Odevixibat
|
XULSCZPZVQIMFM-IPZQJPLYSA-N
|
DB16262
| null |
Olacaftor
|
1897384-89-2
|
RZ7027HK8F
|
Olacaftor
|
NHOUNZMCSIHKHJ-FQEVSTJZSA-N
|
DB16263
| null |
Olaparib-bodipy FL
|
1380359-84-1
|
ZMX54372EH
|
Olaparib-bodipy fl | PARPi-FL
|
IGUTVNUEFKPBGK-UHFFFAOYSA-N
|
DB16264
| null |
Olenasufligene relduparvovec
|
2096510-84-6
|
7DU50HR4GB
|
AAVrh10-h.SGSH | Aavrh10-hsgsh | Dna (recombinant adeno-associated virus 2 vector lys-saf302 human n-sulfoglucosamine sulfohydrolase cdna-specifying) | LYS-SAF302 | Olenasufligene relduparvovec
| null |
DB16265
| null |
Olinvacimab
|
2095504-49-5
|
VFH55IZ5VI
|
Fully human monoclonal antibody targets vascular endothelial growth factor receptor 2 | Immunoglobulin g1, anti-(human vascular endothelial growth factor receptor 2) (human monoclonal ttac-0001 heavy chain), disulfide with human monoclonal ttac-0001 light chain, dimer | Olinvacimab | Tanibirumab
| null |
DB16266
| null |
Olodanrigan
|
1316755-16-4
|
P0FN522VTO
|
Olodanrigan
|
GHBCIXGRCZIPNQ-MHZLTWQESA-N
|
DB16267
| null |
Olutasidenib
|
1887014-12-1
|
0T4IMT8S5Z
|
(s)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile | 2-pyridinecarbonitrile, 5-(((1s)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo- | 5-(((1s)-1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile | Olutasidenib
|
NEQYWYXGTJDAKR-JTQLQIEISA-N
|
DB16268
| null |
Olvimulogene nanivacirepvec
|
1473430-36-2
|
CF19SF72O5
|
Dna (recombinant vaccinia virus strain livp clone gl-onc1) | DNA (synthetic vaccinia virus oncolytic-strain GLV-1h68 (complete genome)) | Olvimulogene nanivacirepvec
| null |
DB16269
| null |
Onfekafusp alfa
|
1957239-88-1
|
6HXC0O6JMV
|
Daromun component l19tnf | Fibromun | Immunoglobulin, anti-(human fibronectin ed-b domain) (synthetic human clone l19 scfv fragment) fusion protein with human tumor necrosis factor .alpha., trimer | Onfekafusp alfa
| null |
DB16270
| null |
Ontuxizumab
|
946415-62-9
|
0M2XT000YC
|
Ontecizumab | Ontuxizumab
| null |
DB16271
| null |
Opiranserin
|
1441000-45-8
|
AP031EC2NI
|
Opiranserin | Vvz-149 free base
|
JQUVQWMHZSYCRQ-UHFFFAOYSA-N
|
DB16272
| null |
Orelabrutinib
|
1655504-04-3
|
WJA5UO9E10
|
Orelabrutinib
|
MZPVEMOYADUARK-UHFFFAOYSA-N
|
DB16273
| null |
Osalmid
|
526-18-1
|
89741L759Z
|
Osalmid
|
LGCMKPRGGJRYGM-UHFFFAOYSA-N
|
DB16274
| null |
Osoresnontrine
|
1189767-28-9
|
O9OC34WOAY
|
Osoresnontrine
|
BZTIJCSHNVZMES-UHFFFAOYSA-N
|
DB16275
| null |
Otlertuzumab
|
1372645-37-8
|
2MZ3L2664T
|
Immunoglobulin, anti-(human cd antigen cd37) (synthetic human-mus musculus fragment tru-016), dimer | Otlertuzumab
| null |
DB16276
| null |
Oxymatrine
|
16837-52-8
|
85U4C366QS
| null |
XVPBINOPNYFXID-JARXUMMXSA-N
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.